Genetic variants linked to higher body mass index (BMI) are associated with lower risk of Parkinson disease, according to a study published by Nicholas Wood and colleagues from the University College London, UK, in PLOS Medicine.
The researchers used a Mendelian randomization approach to examine whether genetic variants linked to higher BMI were also associated with risk of Parkinson disease. The associations between the genetic variants and BMI were obtained from the GIANT consortium and the relationship between the same genetic variants and Parkinson disease was ascertained from a recent meta-analysis that included 13,708 cases of Parkinson disease and 95,282 controls.
The researchers observed that genetic risk expected to confer a lifetime exposure of 5-kg/m2 higher BMI was associated with an 18% lower risk of Parkinson disease (OR 0.82, 95% CI 0.69-0.98). A limitation of the approach is that individuals who have higher BMI have a higher risk of earlier mortality, and therefore individuals with lower BMI may be over-represented amongst individuals diagnosed with Parkinson disease. This “frailty effect” could at least partially account for the estimated association.
The authors say: “Although our results suggest that higher BMI is potentially protective against PD, the negative health impacts of raising BMI are likely to be significant, and should be taken into account.”
For more details click on the link : Alastair J. Noyce, Demis A. Kia, Gibran Hemani, Aude Nicolas, T. Ryan Price, Eduardo De Pablo-Fernandez, Philip C. Haycock, Patrick A. Lewis, Thomas Foltynie, George Davey Smith, Anette Schrag, Andrew J. Lees, John Hardy, Andrew Singleton, Mike A. Nalls, Neil Pearce, Debbie A. Lawlor, Nicholas W. Wood. Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. PLOS Medicine, 2017; 14 (6): e1002314 DOI: 10.1371/journal.pmed.100231